Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omidria infusion in cataract surgery
NCT03864133Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jul 2019
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of phenylephrine + ketorolac in cataract, sponsored by Wake Forest University Health Sciences. Started Jul 2019; status: completed.
02
Drugs
phenylephrine + ketorolac
03
Conditions
cataract
Beyond the preview
Go deeper on NCT03864133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03864133.